Brixton Bio is a startup based in the United States, most recent round Series B, 2 tracked investors.
Brixton Bio is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Brixton Bio is a clinical-stage life sciences company focused on developing novel, drug-free therapies for chronic and acute pain, including its leading product Neural Ice™, an injectable technology designed to provide long-lasting pain relief.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.